Figure 1.
Kidney function (eGFR) in a patient with MMACHC-related disease before and after hydroxocobalamin therapy.

Kidney function (eGFR) in a patient with MMACHC-related disease before and after hydroxocobalamin therapy.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal